phrykt

ADARx Pharmaceuticals, Inc. (ADRX): who owns it and who trades it

As of Nov 13, 2026, ADRX insiders reported 5 purchases worth $33.3M in the last 12 months. The largest buyer was Sr One Capital Management, Llc (10% owner), with $17.1M.

Latest filing Nov 13, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, ADRX insiders reported $33.3M of open-market purchases and $0 of sales.

Purchases, 12 months
$33.3M
5 trades, 3 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Sep 28, 2026
Filed Sep 30, 2026

Purchases and sales by month

$33.3M$33.3MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 28, 2026Erez ChimovitsDirectorPurchase61,516$17.00$1MForm 4
Sep 28, 2026Carl L GordonDirectorPurchase300,249$17.00$5.1MForm 4
Sep 28, 2026Carl L GordonDirectorPurchase588,235$17.00$10MForm 4
Sep 28, 2026Sr One Capital Management, Llc10% ownerPurchase414,814$17.00$7.1MForm 4
Sep 28, 2026Sr One Capital Management, Llc10% ownerPurchase592,593$17.00$10.1MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Sr One Capital Management, Llc10% owner$17.1M–Sep 28, 2026
Carl L GordonDirector, 10% owner$15.1M–Sep 28, 2026
Erez ChimovitsDirector$1M–Sep 28, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ADRX short interest

1.80M ADRX shares are sold short. Over the last 3 reports the number of shares short went up 55%.

As of Oct 30, 2026, 1.80M ADRX shares were sold short, down 5.4% from the report before. At the average daily volume of 358,545 shares, buying them all back would take about 5.0 trading days (days to cover).

Shares short

1.80MSep 30Oct 302.01M

Days to cover

5.0Sep 30Oct 305.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.80M–-5%358,5455.0
Oct 15, 20261.90M–+64%611,7103.1
Sep 30, 20261.16M––669,7711.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

ADARx Pharmaceuticals company events

ADARx Pharmaceuticals filed 1 report on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Sep 28, 2026.

  1. Sep 28, 2026AnnouncementThe Company closed the IPO of 26,250,000 shares of Common Stock at a price to the public of $17.00 per share. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 10 filings named ADRX in the last 120 days.

FiledHolderFormStake
Nov 13, 2026Zhen Li13G9.7%
Nov 13, 2026Zhen Li13G9.7%
Oct 16, 2026LAV Biosciences Fund V, L.P.13G10.5%
Oct 16, 2026LAV Biosciences Fund V, L.P.13G10.5%
Oct 5, 2026SR One Capital Management, LLC13D9.3%
Oct 5, 2026SR One Capital Management, LLC13D9.3%
Oct 2, 2026ORBIMED ADVISORS LLC13D14.0%
Oct 2, 2026ORBIMED ADVISORS LLC13D14.0%
Oct 1, 2026BCLS Fund III Investments, LP13G6.3%
Oct 1, 2026BCLS Fund III Investments, LP13G6.3%

Questions about ADARx Pharmaceuticals, Inc. (ADRX) stock

Are ADRX insiders buying or selling?

In the last 12 months, ADRX insiders reported 5 open-market purchases worth $33.3M and no sales. The latest trade was on Sep 28, 2026. See every trade.

What is the short interest in ADRX?

As of Oct 30, 2026, 1.80M ADRX shares were sold short, down 5.4% from the report before. At the average daily volume of 358,545 shares, buying them all back would take about 5.0 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.